Xynomic Pharmaceuticals Holdings, Inc. is a pharmaceutical-sector company registered with the SEC under CIK 0001697805, with an 8-K filing dated February 27, 2019, bearing accession number 0001213900-19-003185. The company operates in the biopharmaceutical space and became a reporting issuer through a blank-check vehicle structure, a path common among healthcare-focused acquisition companies of that vintage. The February 2019 8-K filing reflects a material corporate event disclosure consistent with post-combination reporting obligations. Sponsor details for the originating acquisition vehicle are available in the full filing record. Visit SpacDesk and sign up for a free account to access complete filing histories, sponsor profiles, and deal timelines for this and hundreds of other SPAC transactions.